Search research articles
Contact Us
Filters
Showing results (51-60 of 115) with videos related to
Page
of 12
Sort By:
Journal of Drugs in Dermatology : JDD
|
July 26, 2013
Onchomycosis: an overview
Boni E Elewski, Phoebe Rich, Antonella Tosti, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2018
Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection
David M Pariser, Martin E Wendelken, Anthony M Rycerz, et al.
Journal of the American Podiatric Medical Association
|
September 26, 2015
Diagnosis and Management of Onychomycosis: Perspectives from a Joint Podiatry-Dermatology Roundtable
Bryan C Markinson, Tracey C Vlahovic, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD
|
September 11, 2015
Onychomycosis Diagnosis and Management: Perspectives from a Joint Dermatology-Podiatry Roundtable
Richard K Scher, Antonella Tosti, Warren S Joseph, et al.
Pediatric Dermatology
|
March 10, 2020
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study
Adelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Clinical and Aesthetic Dermatology
|
February 11, 2020
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study
David M Pariser, Lawrence J Green, Edward L Lain, et al.
Journal of the American Podiatric Medical Association
|
April 1, 2016
Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable
Tracey C Vlahovic, Warren S Joseph, Richard K Scher, et al.
The Journal of Dermatological Treatment
|
March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis
Steven R Feldman, Joseph F Merola, David M Pariser, et al.
Clinical Pharmacology and Therapeutics
|
June 23, 2019
Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe Psoriasis
Gerard Bruin, Anke Hasselberg, Irina Koroleva, et al.
Journal of Drugs in Dermatology : JDD
|
March 9, 2016
Onychomycosis: Strategies to Minimize Recurrence
Aditya K Gupta, Boni E Elewski, Ted Rosen, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 115) with videos related to
Sort By:
Page
of 12
Journal of Drugs in Dermatology : JDD
|
July 26, 2013
Onchomycosis: an overview
Boni E Elewski, Phoebe Rich, Antonella Tosti, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2018
Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection
David M Pariser, Martin E Wendelken, Anthony M Rycerz, et al.
Journal of the American Podiatric Medical Association
|
September 26, 2015
Diagnosis and Management of Onychomycosis: Perspectives from a Joint Podiatry-Dermatology Roundtable
Bryan C Markinson, Tracey C Vlahovic, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD
|
September 11, 2015
Onychomycosis Diagnosis and Management: Perspectives from a Joint Dermatology-Podiatry Roundtable
Richard K Scher, Antonella Tosti, Warren S Joseph, et al.
Pediatric Dermatology
|
March 10, 2020
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study
Adelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Clinical and Aesthetic Dermatology
|
February 11, 2020
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study
David M Pariser, Lawrence J Green, Edward L Lain, et al.
Journal of the American Podiatric Medical Association
|
April 1, 2016
Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable
Tracey C Vlahovic, Warren S Joseph, Richard K Scher, et al.
The Journal of Dermatological Treatment
|
March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis
Steven R Feldman, Joseph F Merola, David M Pariser, et al.
Clinical Pharmacology and Therapeutics
|
June 23, 2019
Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe Psoriasis
Gerard Bruin, Anke Hasselberg, Irina Koroleva, et al.
Journal of Drugs in Dermatology : JDD
|
March 9, 2016
Onychomycosis: Strategies to Minimize Recurrence
Aditya K Gupta, Boni E Elewski, Ted Rosen, et al.
Page
of 12